Benefit From A Brand New Oncology Stream Introduced At The Pricing, Reimbursement & Market Access In Pharma Conference, 17-18 January 2013, Barcelona

Date: Oct-12-2012With the government trying to cut down costs on health spending, market access for oncology therapeutics is becoming more complicated and difficult. On the other hand, oncology medications, which are usually considered to be especially innovative, are increasing in demand.

To ensure a better and faster way of collaboration between industry, regulation and payers and help meet the ultimate goal - patient access to innovative medications, Fleming Europe has decided to include a brand new stream on Oncology market access to its 8th Annual Pricing, Reimbursement & Market Access In Pharma conference.

Taking place on 17 - 18 January 2013 in Barcelona, this conference will promote a wide range of presentations, practical case studies, interactive sessions and debates by bringing together 80 - 120 senior experts from the field of pricing, reimbursement and market access.

The stream A will bring the focus on breaking issues and strategic insights into pricing and reimbursement, the power of patients, smoother access from regional perspectives, innovations in healthcare and the role of HTAs.

Top pharma companies will share their experiences and the attendees will have a unique opportunity to hear about their best practices and their impact on the market:

How is the AMNOG shaping up?The power of patientsRisk-sharing success stories in the UKDrug assessment in France one year after the new legislative context Budget cuts in Italy - How does the market react?The role of HTA in Spain

Topics covering oncology market access, will be presented and discussed in the framework of the stream B. 6 presentations, 6 case studies and 3 interactive discussions will reveal the future drivers in oncology in order to customize the product value story and compete for premium reimbursement:

Integrated market access strategiesHomecare programs in oncologyUtilization of risk-sharing schemesReimbursement challenges for personalized medicineOECD project on pharmaceutical value-based pricing

Come to Barcelona and meet Senior Vice Presidents, Vice Presidents, Senior Executives, Heads, Directors, Managers, Advisors, Strategists and Analysts of Pharmaceutical companies responsible for Pricing, Reimbursement, Market Access, HTA Policy, Government Affairs and extend your stock of information and valuable advice from qualified experts.

If you want to be up-to-date with the latest developments in the areas of pricing, reimbursement and market access, join our Pharma Market Access Forum.

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.